Thermo Fisher Scientific Inc., US8835561023

Thermo Fisher Scientific stock: Results due October 21 for Thermo Fisher Scientific stock

Published on 10/20/2026 at 17:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue rose 10.00 percent. Thermo Fisher Scientific stock costs EUR 609.20 on October 20, 2026, down 1.30 percent versus Frankfurt close.

Quarterly results and valuation

Thermo Fisher Scientific will publish third-quarter results before the market opens on October 21, 2026.
Second-quarter revenue rose 10.00 percent year over year to USD 11.99 billion.
Thermo Fisher Scientific stock costs EUR 609.20 at Lang & Schwarz on October 20, 2026 at 5:10 p.m. CEST, 1.30 percent below the Frankfurt close of October 19, 2026.
The company reported an adjusted operating margin of 22.80 percent in the second quarter of 2026.

Trading-Floor mit großen Bildschirmen, Kursdiagrammen und DNA-Grafiken, Händler an Arbeitsplätzen — Börsen-Editorial visualisiert Thermo Fisher Sci. US8835561023 mit Handelssaal, Kursdiagrammen und Biotech-Molekülgrafiken auf Bildschirmen, Illustration mit AI erstellt.

Thermo Fisher Scientific will release its third-quarter 2026 results before the U.S. market opens on October 21, 2026, after announcing the schedule on September 28, 2026. The company said in its investor release that the conference call will start at 7:00 a.m. ET. At Lang & Schwarz, the stock was trading at EUR 609.20 on October 20, 2026 at 5:10 p.m. CEST, down 1.30 percent versus the Frankfurt close of October 19, 2026 at EUR 617.20.

Revenue growth sets the bar

The latest reported quarter provides the operating benchmark for the upcoming release. In the second quarter of 2026, revenue rose 10.00 percent year over year to USD 11.99 billion, while organic revenue growth was 5.00 percent. Adjusted earnings per share increased 13.00 percent to USD 6.03, and the adjusted operating margin expanded to 22.80 percent from 21.90 percent a year earlier, according to Yahoo Finance on October 11, 2026.

Stock position before results

The U.S. listing closed at USD 679.38 on October 19, 2026, according to a market overview dated October 20, 2026. The same overview placed the 52-week range at USD 435.27 to USD 704.00 and the year-to-date gain at 26.60 percent. The euro quotation is therefore below the recent Frankfurt close even as the primary listing remains near its yearly high.

Valuation and reporting date

The next scheduled corporate date is October 21, 2026, when Thermo Fisher Scientific is due to publish third-quarter results and host its earnings call. The second-quarter figures put the upcoming report in a clear comparison frame: reported revenue growth was 10.00 percent, but organic growth was 5.00 percent. That gap will remain central to how investors assess the durability of the recovery.

Comparison with peers

Thermo Fisher Scientific: down 1.30 percent versus the Frankfurt close, 26.10 times expected adjusted earnings, market capitalization USD 251.20 billion. Danaher Corporation (NYSE, USD): up 0.32 percent, P/E 40.14, market capitalization USD 158.30 billion. Illumina, Inc. (Nasdaq, USD): up 2.18 percent, P/E 50.05, market capitalization USD 40.50 billion.

Price and reporting focus

The immediate reference point is the October 21 results release, while the operating figures offer a measurable test for the company's valuation. Thermo Fisher Scientific stock was trading at EUR 609.20 at Lang & Schwarz on October 20, 2026 at 5:10 p.m. CEST, 1.30 percent below the Frankfurt close of October 19, 2026 at EUR 617.20. The further course of trading is shown by the continuously updated real-time quote of Thermo Fisher Scientific stock.